Insider Transactions in Q3 2023 at Cortexyme, Inc. (CRTX)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 31
2023
|
David Lamond |
BUY
Open market or private purchase
|
Indirect |
41,026
+1.85%
|
$41,026
$1.32 P/Share
|
Aug 30
2023
|
David Lamond |
BUY
Open market or private purchase
|
Indirect |
41,026
+1.88%
|
$41,026
$1.31 P/Share
|
Aug 17
2023
|
David Lamond |
BUY
Open market or private purchase
|
Indirect |
24,766
+1.17%
|
$24,766
$1.29 P/Share
|
Aug 16
2023
|
David Lamond |
BUY
Open market or private purchase
|
Indirect |
117,348
+5.36%
|
$117,348
$1.29 P/Share
|
Aug 15
2023
|
David Lamond |
BUY
Open market or private purchase
|
Indirect |
107,886
+5.23%
|
$107,886
$1.32 P/Share
|
Aug 10
2023
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
88,000
+16.39%
|
$88,000
$1.26 P/Share
|
Aug 08
2023
|
Brendan Hannah CHIEF BUSINESS OFFICER AND COO |
BUY
Open market or private purchase
|
Direct |
71,762
+26.26%
|
$71,762
$1.22 P/Share
|
Aug 08
2023
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
80,000
+18.14%
|
$80,000
$1.24 P/Share
|
Aug 08
2023
|
Margaret Mc Loughlin |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$8,000
$1.23 P/Share
|